Baskhanbiopharma (XKRX:354390) Total Inventories : ₩4,042 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Baskhanbiopharma Total Inventories?

Baskhanbiopharma's total inventories for the quarter that ended in Dec. 2024 was ₩4,042 Mil. Baskhanbiopharma's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Dec. 2024 was ₩3,977 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Baskhanbiopharma's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was ₩1,517.02.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Baskhanbiopharma's Days Inventory for the six months ended in Dec. 2024 was 33.16.

Inventory Turnover measures how fast the company turns over its inventory within a year. Baskhanbiopharma's Inventory Turnover for the quarter that ended in Dec. 2024 was 5.50.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Baskhanbiopharma's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.14.

Baskhanbiopharma Total Inventories Historical Data

The historical data trend for Baskhanbiopharma's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baskhanbiopharma Total Inventories Chart

Baskhanbiopharma Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Total Inventories

3,015.84

2,733.38

3,050.00

3,910.97

4,042.11

Baskhanbiopharma Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23	Dec24
Total Inventories	3,015.84	2,733.38	3,050.00	3,910.97	4,042.11

Baskhanbiopharma Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Baskhanbiopharma (XKRX:354390) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Baskhanbiopharma's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

	Net-Net Working Capital Per Share (Q: Dec. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(5349.478	+	0.75 * 10222.41	+	0.5 * 4042.106	-	4401.511
-	0	-	0)	/	7.011
=	1,517.02

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Baskhanbiopharma's Days Inventory for the six months ended in Dec. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2024 )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
	=	3976.539	/	21886.968	*	365 / 2
	=	33.16

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Baskhanbiopharma's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2024 )	/	Average Total Inventories (Q: Dec. 2024 )
	=	21886.968	/	3976.539
	=	5.50

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Baskhanbiopharma's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	3976.539	/	28852.124
	=	0.14

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Baskhanbiopharma Total Inventories Related Terms

Thank you for viewing the detailed overview of Baskhanbiopharma's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Baskhanbiopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Total Inventories

Traded in Other Exchanges

N/A

Address

354 Wondang-ro, Wongok-myeon, Anseong-si, Gyeonggi-do, KOR

Website

https://www.baskhanbio.com

Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.

Baskhanbiopharma Headlines

No Headlines